David Hatch
Foot & Ankle Surgery · Tucson, AZNPI 1003295643
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Arthrex at 24.9% of the total.
Across 272 payments — averaging $70.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- International Rehabilitative Sciences, Inc$3K
- Impactortho, Inc.$2K
- Paragon 28, Inc.$2K
- Smith+Nephew$1K
- Stryker$1K
- plus $4K from 34 others
What the payments were for
- Travel & lodging$3,49418%
- Food & beverage$7,60440%
- Education$4,80025%
- Other$3,32817%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RS-4i Plus with Intersperse$3,328
- Product Portfolio$980
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$576
- CADENCE ANKLE REPLACEMENT SYSTEM$576
- HALLU-LOCK$576
- PANTA NAIL$576
- TOTAL FOOT SYSTEM$576
- PROstep$561
- Synthecure$154
- ORTHOLOC 3DI$149
- N/A$123
- ENROUTE Transcarotid Neuroprotection System$106
- ENROUTE Transcarotid Stent System$106
- ENHANCE Transcarotid Peripheral Access Kit$106
- ENROUTE 0.014 Guidewire$106
How this compares
$19,226 in reported general payments places this provider in the 85th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 80 | $953 |
| Linezolid | 13 | $714 |
| Ammonium Lactate | 30 | $684 |
| Cephalexin | 36 | $550 |
| Diclofenac Sodium | 15 | $415 |
| Doxycycline Hyclate | 19 | $362 |
| Terbinafine Hcl | 20 | $359 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $272 |
| Mupirocin | 29 | $252 |
| ErythromycinErythromycin Base | 19 | $211 |
| Tramadol Hcl | 32 | $196 |
| Pregabalin | 14 | $167 |
| Triamcinolone Acetonide | 16 | $156 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $127 |
| Nystatin | 11 | $120 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Tucson
- Geoffrey LandisTucson$307K
- Bryan HallTucson$74K
- Jerome SteckTucson$64K
- Joseph BakerTucson$35K
- George AbdelmessiehTucson$25K
- Mohanad EltahirTucson$24K
- Gregory WalkerTucson$18K
- Jordan CraftonTucson$17K
- Richard QuintTucson$17K
- Grant SchindlerTucson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.